Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial

REFERENCES

1. 1.↵
   2. Kurosawa Y,
   3. Lu A,
   4. Khatri P, et al

   . Intra-arterial iodinated radiographic contrast material injection administration in a rat middle cerebral artery occlusion and reperfusion model: possible effects on intracerebral hemorrhage. Stroke 2010;41:1013–17 doi:10.1161/STROKEAHA.110.578245 pmid:20360541

   Abstract/FREE Full Text
2. 2.↵
   2. Morales H,
   3. Lu A,
   4. Kurosawa Y, et al

   . Decreased infarct volume and intracranial hemorrhage associated with intra-arterial nonionic iso-osmolar contrast material in an MCA occlusion/reperfusion model. AJNR Am J Neuroradiol 2014;35:1885–91 doi:10.3174/ajnr.A3953 pmid:24812016

   Abstract/FREE Full Text
3. 3.↵
   2. Dzialowski I,
   3. Puetz V,
   4. Buchan AM, et al

   ; Calgary Stroke Program. Does the application of x-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients? Stroke 2012;43:1567–71 doi:10.1161/STROKEAHA.112.651737 pmid:22496336

   Abstract/FREE Full Text
4. 4.↵
   2. Broderick JP,
   3. Palesch YY,
   4. Demchuk AM, et al

   ; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893–903 doi:10.1056/NEJMoa1214300 pmid:23390923

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Khatri P,
   3. Hill M,
   4. Palesch Y, et al

   ; Interventional Management of Stroke III Investigators. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008;3:130–37 doi:10.1111/j.1747-4949.2008.00151.x pmid:18706007

   Abstract/FREE Full Text
6. 6.↵
   2. Tomsick T,
   3. Broderick J,
   4. Carrozella J, et al

   ; IMS II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582–87 doi:10.3174/ajnr.A0843 pmid:18337393

   Abstract/FREE Full Text
7. 7.↵
   2. Smith WS,
   3. Sung G,
   4. Starkman S, et al

   ; MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38 doi:10.1161/01.STR.0000171066.25248.1d pmid:15961709

   Abstract/FREE Full Text
8. 8.↵
   2. Smith WS,
   3. Sung G,
   4. Saver J, et al

   . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12 doi:10.1161/STROKEAHA.107.497115 pmid:18309168

   Abstract/FREE Full Text
9. 9.↵
   Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68 doi:10.1161/STROKEAHA.108.544957 pmid:19590057

   Abstract/FREE Full Text
10. 10.↵
    2. Dávalos A,
    3. Pereira VM,
    4. Chapot R, et al

    ; Solitaire Group. Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke 2012;43:2699–705 doi:10.1161/STROKEAHA.112.663328 pmid:22851547

    Abstract/FREE Full Text
11. 11.↵
    2. Kendall BE,
    3. Pullicino P

    . Intravascular contrast injection in ischaemic lesions, II: effect on prognosis. Neuroradiology 1980;19:241–43 pmid:7393448

    PubMedWeb of Science
12. 12.↵
    2. Doerfler A,
    3. Engelhorn T,
    4. von Kummer R, et al

    . Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats. Radiology 1998;206:211–17 doi:10.1148/radiology.206.1.9423675 pmid:9423675

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Diedler J,
    3. Ahmed N,
    4. Sykora M, et al

    . Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke 2010;41:288–94 doi:10.1161/STROKEAHA.109.559724 pmid:20056933

    Abstract/FREE Full Text
14. 14.↵
    2. Hayman LA,
    3. Evans RA,
    4. Bastion FO, et al

    . Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. AJR Am J Roentgenol 1981;136:1151–59 doi:10.2214/ajr.136.6.1151 pmid:6786028

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Chronos NA,
    3. Goodall AH,
    4. Wilson DJ, et al

    . Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993;88:2035–44 doi:10.1161/01.CIR.88.5.2035 pmid:8222096

    Abstract/FREE Full Text
16. 16.↵
    2. Corot C,
    3. Chronos N,
    4. Sabattier V

    . In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coagul Fibrinolysis 1996;7:602–08 doi:10.1097/00001721-199609000-00005 pmid:8899149

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Jones CI,
    3. Goodall AH

    . Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis. Thromb Res 2003;112:65–71 doi:10.1016/j.thromres.2003.09.031 pmid:15013276

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Dalby MC,
    3. Davidson SJ,
    4. Burman JF, et al

    . Systemic platelet effects of contrast media: implications of cardiologic research and clinical practice. Am Heart J 2002;143:E1 pmid:11773932

    PubMed
19. 19.↵
    2. Markou CP,
    3. Chronos NA,
    4. Hanson SR

    . Antithromotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb Haemost 2001;85:488–93 pmid:11307820

    PubMedWeb of Science
20. 20.↵
    2. Li X,
    3. Gabriel DA

    . Differences between contrast media in the inhibition of platelet activation by specific platelet agonists. Acad Radiol 1997;4:108–14 doi:10.1016/S1076-6332(97)80009-8 pmid:9061083

    CrossRefPubMedWeb of Science
21. 21.↵
    NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28: 2119–25 doi:10.1161/01.STR.28.11.2119 pmid:9368551

    Abstract/FREE Full Text
22. 22.↵
    NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109–18 doi:10.1161/01.STR.28.11.2109 pmid:9368550

    Abstract/FREE Full Text
23. 23.↵
    2. Marcos SK,
    3. Thomsen HS,
    4. Exley CM

    ; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast media: interactions with other drugs and clinical tests. Eur Radiol 2005;15:1463–68 doi:10.1007/s00330-004-2600-1 pmid:15968520

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Frohlich JM

    . Systematic survey of interactions between contrast media and other drugs. Special edition by Guerbet Switzerland; 2001
25. 25.↵
    2. Corot C,
    3. Perrin JM,
    4. Belleville J, et al

    . Effect of iodinated contrast media on blood clotting. Invest Radiol 1989;24:390–93 doi:10.1097/00004424-198905000-00010 pmid:2745021

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Ing JJ,
    3. Smith DC,
    4. Bull BS

    . Differing mechanisms of clotting inhibition by ionic and nonionic contrast agents. Radiology 1989;172:345–48 doi:10.1148/radiology.172.2.2748812 pmid:2748812

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Kopko PM,
    3. Smith DC,
    4. Bull BS

    : Thrombin generation in nonclottable mixtures of blood and nonionic contrast agents. Radiology 1990;174:459–61 doi:10.1148/radiology.174.2.2296655 pmid:2296655

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Georgakis A,
    3. Ener RA,
    4. Jin J, et al

    . Risk of thrombogenicity among nonionic radiocontrast agents. J Invasive Cardiol 2008;20:349–53 pmid:18599893

    PubMed
29. 29.↵
    2. LaBounty TM,
    3. Shah M,
    4. Raman SV, et al

    . Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. Am J Cardiol 2012;109:1594–99 doi:10.1016/j.amjcard.2012.01.380 pmid:22440116

    CrossRefPubMed
30. 30.↵
    2. Sutton AG,
    3. Ashton VJ,
    4. Campbell PG, et al

    . A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2002;57:346–52 doi:10.1002/ccd.10326 pmid:12410513

    CrossRefPubMed
31. 31.↵
    2. Dehmer GJ,
    3. Gresalfi N,
    4. Daly D, et al

    . Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol 1995;25:1069–75 doi:10.1016/0735-1097(94)00528-X pmid:7897118

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Pislaru S,
    3. Pislaru C,
    4. Szilard M, et al

    . In vivo effects of contrast media on coronary thrombolysis. Am Coll Cardiol 1998;32:1102–08 doi:10.1016/S0735-1097(98)00326-X

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Van Beek EJ,
    3. Levi M,
    4. Reekers JA, et al

    . Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography. Radiology 1994;193:821–23 doi:10.1148/radiology.193.3.7972831 pmid:7972831

    CrossRefPubMed
34. 34.↵
    2. Hill V,
    3. Meunier J,
    4. Shaw GJ, et al

    . Effect of iodixanol on rt-PA thrombolysis in human clots. In: Proceedings of the Annual Meeting of the American Society of Neuroradiology and Neuroradiology Education and Research Foundation Symposium, Boston, Massachusetts. May 16–20, 2010
35. 35.↵
    2. Dani KA,
    3. Muir KW

    . Do iodinated contrast agents impair fibrinolysis in acute stroke? A systematic review. AJNR Am J Neuroradiol 2010;31:170–74 doi:10.3174/ajnr.A1782 pmid:19749221

    Abstract/FREE Full Text
36. 36.↵
    2. Franke RP,
    3. Fuhrmann R,
    4. Hiebl B, et al

    . Influence of various radiographic contrast media on the buckling of endothelial cells. Microvasc Res 2008;76:110–13 doi:10.1016/j.mvr.2008.05.002 pmid:18619981

    CrossRefPubMed
37. 37.↵
    2. Franke RP,
    3. Fuhrmann R,
    4. Park JW, et al

    . The effect of radiographic contrast media on the morphology of human venous endothelial cells. Clin Hemorheol Microcirc 2007;37:329–38 pmid:17942985

    PubMed
38. 38.↵
    2. Aspelin P,
    3. Stacul F,
    4. Thomsen HS, et al

    ; Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Effects of iodinated contrast media on blood and endothelium. Eur Radiol 2006;16:1041–49 doi:10.1007/s00330-005-0081-5 pmid:16395531

    CrossRefPubMed
39. 39.↵
    2. Jung F,
    3. Mrowietz C,
    4. Rickert D, et al

    . The effect of radiographic contrast media on the morphology of human erythrocytes. Clin Hemorheol Microcirc 2008;38:1–11 pmid:18094453

    PubMed
40. 40.↵
    2. Aulie Michelet A

    . Effects of intravascular contrast media on blood-brain barrier: comparison between iothalamate, iohexol, iopentol, and iodixanol. Acta Radiol 1987;28:329–33 doi:10.1177/028418518702800320 pmid:2958041

    Abstract/FREE Full Text
41. 41.↵
    2. Sage MR,
    3. Wilson AJ,
    4. Scroop R

    . Contrast media and the brain: the basis of CT and MR imaging enhancement. Neuroimaging Clin N Am 1998;8:695–707 pmid:9673320

    PubMed
42. 42.↵
    2. Sage MR,
    3. Wilcox J,
    4. Evill CA, et al

    . Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate. AJNR Am J Neuroradiol 1983;4:893–95 pmid:6410875

    Abstract/FREE Full Text
43. 43.↵
    2. Whisson CC,
    3. Wilson AJ,
    4. Evill CA, et al

    . The effect of intracarotid nonionic contrast media on the blood-brain barrier in acute hypertension. AJNR Am J Neuroradiol 1994;15:95–100 pmid:8141072

    Abstract/FREE Full Text
44. 44.↵
    2. Lee KK,
    3. Kang DH,
    4. Kim YS, et al

    . Serious blood brain disruption after coil embolization of unruptured intracranial aneurysm: report of two cases and role of immediate postembolization CT scan. J Korean Neurosurg Soc 2011;50:45–47 doi:10.3340/jkns.2011.50.1.45 pmid:21892404

    CrossRefPubMed
45. 45.↵
    2. Ozturk A,
    3. Saatci I,
    4. Pamuk , et al

    . Focal increased cortical density in immediate postembolization CT scans of patients with intracranial aneurysms. AJNR Am J Neuroradiol 2006;27:1866–75 pmid:17032858

    Abstract/FREE Full Text
46. 46.↵
    2. Hayakawa K,
    3. Morris TM,
    4. Katzberg RW

    . Opening of the blood-brain barrier by intravenous contrast media in euvolemic and dehydrated rabbits. Acta Radiol 1989;30:439–44 doi:10.1177/028418518903000421 pmid:2505832

    Abstract/FREE Full Text
47. 47.↵
    2. Murphy A,
    3. Heran M,
    4. Smith A, et al

    . Intra-arterial thrombolysis and parenchymal contrast staining: determining its meaning in the setting of acute stroke intervention. In: Proceedings of the Annual Meeting of the American Society of Neuroradiology and Neuroradiology Education and Research Foundation Symposium, Vancouver, British Columbia, Canada. May 18–21, 2009:375
48. 48.↵
    2. Knight RA,
    3. Barker PB,
    4. Fagan SC, et al

    . Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 1998;29:144–51 doi:10.1161/01.STR.29.1.144 pmid:9445344

    Abstract/FREE Full Text
49. 49.↵
    2. Neumann-Haefelin C,
    3. Brinker G,
    4. Uhlenküken U, et al

    . Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain. Stroke 2002;33:1392–98 doi:10.1161/01.STR.0000014619.59851.65 pmid:11988620

    Abstract/FREE Full Text
50. 50.↵
    2. Hom J,
    3. Dankbaar JW,
    4. Soares BP, et al

    . Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol 2011;32:41–48 doi:10.3174/ajnr.A2244 pmid:20947643

    Abstract/FREE Full Text
51. 51.↵
    2. Aviv RI,
    3. d'Esterre CD,
    4. Murphy BD, et al

    . Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology, 2009;250:867–77 doi:10.1148/radiol.2503080257 pmid:19244051

    CrossRefPubMedWeb of Science
52. 52.↵
    2. Lin K,
    3. Kazmi KS,
    4. Law M, et al

    . Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol, 2007;28:1292–98 doi:10.3174/ajnr.A0539 pmid:17698530

    Abstract/FREE Full Text
53. 53.↵
    2. Kim EY,
    3. Kim SS,
    4. Na DG, et al

    . Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation. J Comput Assisted Tomogr 2005;29:264–69 doi:10.1097/01.rct.0000155669.05643.49 pmid:15772550

    CrossRefPubMed
54. 54.↵
    2. Hjort N,
    3. Wu O,
    4. Ashkanian M, et al

    . MRI detection of early blood brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis. Stroke 2008;39:1025–28 doi:10.1161/STROKEAHA.107.497719 pmid:18258832

    Abstract/FREE Full Text
55. 55.↵
    2. Latour LL,
    3. Kang DW,
    4. Ezzeddine MA, et al

    . Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004;56:468–77 doi:10.1002/ana.20199 pmid:15389899

    CrossRefPubMedWeb of Science
56. 56.↵
    2. Lummul N,
    3. Schulte-Altedorneburg G,
    4. Bernau C, et al

    . Hyperattenuated intracerebral lesions after mechanical revascularization in acute stroke. AJNR Am J Neuroradiol 2014;35:345–51 doi:10.3174/ajnr.A3656 pmid:23907245

    Abstract/FREE Full Text
57. 57.↵
    2. Pannu N,
    3. Wiebe N,
    4. Tonelli M

    . Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765–79 doi:10.1001/jama.295.23.2765 pmid:16788132

    CrossRefPubMedWeb of Science
58. 58.↵
    2. Fountaine H,
    3. Harnish P,
    4. Andrew E, et al

    . Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. Acad Radiol 1996;3(suppl 3):S475-84 doi:10.1016/S1076-6332(05)80362-9 pmid:8883524

    CrossRefPubMed
59. 59.↵
    2. Heinrich MC,
    3. Kuhlmann MK,
    4. Grgic A, et al

    . Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 2005;235:843–49 doi:10.1148/radiol.2353040726 pmid:15845795

    CrossRefPubMedWeb of Science
60. 60.↵
    2. Dooley M,
    3. Jarvis B

    . Iomeprol: a review of its use as a contrast medium. Drugs 2000;59:1169–86 doi:10.2165/00003495-200059050-00013 pmid:10852647

    CrossRefPubMedWeb of Science
61. 61.↵
    2. McClennan BL,
    3. Stolberg HO

    . Intravascular contrast media: ionic versus nonionic: current status. Radiol Clin North Am 1991;29:437–54 pmid:2023999

    PubMedWeb of Science
62. 62.↵
    2. Lasser EC,
    3. Lang JH

    . Inhibition of acetylcholinesterase by some organic contrast media: a preliminary communication. Invest Radiol 1966;2:237–42 pmid:5938802

    PubMed
63. 63.↵
    2. Gertz EW

    . Thromboembolic events and non-ionic contrast. Diagn Imag 1989;11:106–09
64. 64.↵
    2. Paczynski RP,
    3. He YY,
    4. Diringer , et al

    . Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke 1997;28:1437–43; discussion 1444 pmid:9227697

    Abstract/FREE Full Text
65. 65.↵
    2. Wilcox J,
    3. Wilson AJ,
    4. Evill CA, et al

    . A comparison of blood-brain barrier disruption by intracarotid iohexol and iodixanol in the rabbit. AJNR Am J Neuroradiol 1987;8:769–72 pmid:2823587

    Abstract/FREE Full Text
66. 66.↵
    2. Macdougall NJ,
    3. McVerry F,
    4. Baird S, et al

    . Iodinated contrast media and cerebral hemorrhage after intravenous thrombolysis. Stroke 2011;42:2170–74 doi:10.1161/STROKEAHA.111.618777 pmid:21737802

    Abstract/FREE Full Text
67. 67.↵
    2. Khatri P,
    3. Broderick JP,
    4. Khoury JC, et al

    ; IMS I and II Investigators. Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk. Stroke 2008;39:3283–87 doi:10.1161/STROKEAHA.108.522904 pmid:18772441

    Abstract/FREE Full Text
68. 68.↵
    2. Leong S,
    3. Fanning NF

    . Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling: a case report and review of the literature. Interv Neuroradiol 2012;18:33–41 pmid:22440599

    Abstract/FREE Full Text
69. 69.↵
    2. Wilcox J,
    3. Sage MR

    . Is viscosity important in the production of blood-brain barrier disruption by intracarotid contrast media? Neuroradiology 1984;26:511–13 doi:10.1007/BF00342690 pmid:6504320

    CrossRefPubMed
70. 70.↵
    2. Sood R,
    3. Taheri S,
    4. Estrada EY, et al

    . Quantitative evaluation of the effect of propylene glycol on BBB permeability. J Magn Reson Imaging 2007;25:39–47 doi:10.1002/jmri.20802 pmid:17173307

    CrossRefPubMed
71. 71.↵
    2. Jacobsen PB,
    3. Larsen A,
    4. Konarboland R, et al

    . Biotransformation of nonionic x-ray contrast agents in vivo and in vitro. Drug Metab Dispos 1999;27:1205–13 pmid:10497149

    Abstract/FREE Full Text
72. 72.↵
    2. Spencer CM,
    3. Goa KL

    . Iodixanol: a review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs 1996;52:899–927 doi:10.2165/00003495-199652060-00013 pmid:8957160

    CrossRefPubMed
73. 73.↵
    2. Molina CA,
    3. Montaner J,
    4. Abilleira S, et al

    . Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke 2001;32:1079–84 doi:10.1161/01.STR.32.5.1079 pmid:11340213

    Abstract/FREE Full Text
74. 74.↵
    2. Simard JM,
    3. Kent TA,
    4. Chen M, et al

    . Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 2007;6:258–68 doi:10.1016/S1474-4422(07)70055-8 pmid:17303532

    CrossRefPubMedWeb of Science
75. 75.↵
    2. Zador Z,
    3. Stiver S,
    4. Wang V, et al

    . Role of aquaporin-4 in cerebral edema and stroke. Handb Exp Pharmacol 2009:159–70 doi:10.1007/978-3-540-79885-9_7 pmid:19096776

    CrossRefPubMed
76. 76.↵
    2. Lu A,
    3. Clark JF,
    4. Broderick JP, et al

    . Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol 2009;216:407–12 doi:10.1016/j.expneurol.2008.12.020 pmid:19162014

    CrossRefPubMed
77. 77.↵
    2. Dirnagl U,
    3. Lindauer U,
    4. Them A, et al

    . Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab 1995;15:929–40 doi:10.1038/jcbfm.1995.118 pmid:7593353

    Abstract/FREE Full Text
78. 78.↵
    2. Kumura E,
    3. Yoshimine T,
    4. Iwatsuki KI, et al

    . Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats. Am J Physiol 1996;270(3 pt 1):C748-52 pmid:8638653

    PubMed
79. 79.↵
    2. Lu A,
    3. Clark JF,
    4. Broderick JP, et al

    . Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol 2008;210:549–59 doi:10.1016/j.expneurol.2007.12.003 pmid:18187134

    CrossRefPubMed
80. 80.↵
    2. Rosell A,
    3. Foerch C,
    4. Murata Y, et al

    . Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir Suppl 2008;105:173–78 doi:10.1007/978-3-211-09469-3_34 pmid:19066105

    CrossRefPubMed
81. 81.↵
    2. Schwartz D,
    3. Blum M,
    4. Peer G, et al

    . Role of nitric oxide (EDRF) in radiocontrast acute renal failure in rats. Am J Physiol 1994;267:F374-79 pmid:8092251

    PubMedWeb of Science
82. 82.↵
    2. Heyman SN,
    3. Goldfarb M,
    4. Carmeli F, et al

    . Effect of radiocontrast agents on intrarenal nitric oxide (NO) and NO synthase activity. Exp Nephrol 1998;6:557–62 doi:10.1159/000020571 pmid:9807028

    CrossRefPubMed
83. 83.↵
    2. Treitl M,
    3. Rupprecht H,
    4. Wirth S, et al

    . Assessment of renal vasoconstriction in vivo after intra-arterial administration of the isosmotic contrast medium iodixanol compared to the low-osmolar contrast medium iopamidol. Nephrol Dial Transplant 2009;24:1478–85 doi:10.1093/ndt/gfn638 pmid:19033249

    Abstract/FREE Full Text
84. 84.↵
    2. Morris TW,
    3. Ekholm SE,
    4. Prentice L, et al

    . Iotrol, iodixanol, and 2-deoxy-D-glucose effects on neural tissue CO2 production. AJNR Am J Neuroradiol 1989;10:1123–26 pmid:2505529

    Abstract/FREE Full Text
85. 85.↵
    2. Kim SJ,
    3. Salem MR,
    4. Joseph NJ, et al

    . Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg 1990;71:73–76 pmid:2363533

    PubMedWeb of Science
86. 86.↵
    2. Uchiyama Y,
    3. Abe T,
    4. Tanaka N, et al

    . Factors contributing to blood-brain barrier disruption following intracarotid injection of nonionic iodinated contrast media for cerebral angiography: experimental study in rabbits. Radiat Med 2006;24:321–26 doi:10.1007/s11604-006-0030-5 pmid:16958409

    CrossRefPubMed
87. 87.↵
    2. Khatri R,
    3. Khatri P,
    4. Khoury J, et al

    . Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk. J Neurointerv Surg 2010;2:115–19 doi:10.1136/jnis.2009.000794 pmid:21990590

    Abstract/FREE Full Text
88. 88.↵
    2. Al-Ali F,
    3. Elias JJ,
    4. Tomsick TA, et al

    ; IMS Study Groups. Relative influence of capillary index score, revascularization, and time on stroke outcomes from the Interventional Management of Stroke III Trial. Stroke 2015;46:1590–94 doi:10.1161/STROKEAHA.115.009066 pmid:25953374

    Abstract/FREE Full Text